Hunter Moore, MD
Transplant Surgery · Aurora, CONPI 1144519935
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (42.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Grifols Shared Services North America, Inc. at 57.0% of the total. 2025 is the largest year on record at $16,900, more than ten times the $1,000 reported in 2021.
Across 50 payments — averaging $557.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Grifols Shared Services North America, Inc.$16K
- Intuitive Surgical$6K
- Instrumentation Laboratory Company$3K
- Hemosonics LLC$1K
- Haemonetics Corporation$573
- TELA Bio, Inc.$339
- plus $495 from 13 others
Across 25 payments — averaging $18,499 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Haemonetics Corporation$433K
- Xvivo Perfusion Inc.$30K
What the payments were for
- Consulting fees$11,83842%
- Travel & lodging$9,89835%
- Food & beverage$1,6026%
- Education$4,55816%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Grifols Shared Services North America, Inc. | 8 | $15,909 |
| Intuitive Surgical | 15 | $6,495 |
| Instrumentation Laboratory Company | 3 | $3,084 |
| Hemosonics LLC | 1 | $1,000 |
| Haemonetics Corporation | 6 | $573 |
| TELA Bio, Inc. | 2 | $339 |
| Boston Scientific | 1 | $128 |
| Johnson & Johnson | 3 | $76 |
| AMAG Pharmaceuticals, Inc. | 1 | $35 |
| Novo Nordisk | 1 | $35 |
| Octapharma USA, Inc. | 1 | $31 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $28 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| Innovation Technologies Inc | 1 | $26 |
| Medtronic | 1 | $22 |
| Mimedx Group, Inc. | 1 | $20 |
| Orphalan Inc | 1 | $19 |
| Novartis | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,895 in reported general payments places this provider in the 85th percentile of 22 transplant surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Folic Acid | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Aurora
- Thomas PshakAurora$33K
- Peter KennealeyAurora$31K
- Phillipe Geraldo Teixeira de Abreu ReisAurora$7K
- Kendra ConzenAurora$5K
- Rashikh ChoudhuryAurora$4K
- Perveshinder GrewalAurora$3K
- Trevor NydamAurora$2K
- James PomposelliAurora$1K
- Kristin MekeelAurora$1K
- Thomas BakAurora$840
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.